Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Phrenic nerve stimulation in patients with central sleep apnea: a single‑center experience from pilot and pivotal trials evaluating the remedē System.

Jagielski D, Kołodziej A, Westlund R, Biel B, Nowak K, Szemplińska I, Flinta I, Krawczyk M, Kulej K, Krakowiak B, Germany R, Panteleon A, McKane S, Banasiak W, Abraham WT, Ponikowski P.

Kardiol Pol. 2019 May 24;77(5):553-560. doi: 10.5603/KP.a2019.0061. Epub 2019 Apr 9.

2.

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.

Kaye DM, Petrie MC, McKenzie S, Hasenfuβ G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C; REDUCE LAP-HF study investigators.

ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.

3.

High-Throughput Preparation of Metal Oxide Nanocrystals by Cathodic Corrosion and Their Use as Active Photocatalysts.

Kromer ML, Monzó J, Lawrence MJ, Kolodziej A, Gossage ZT, Simpson BH, Morandi S, Yanson A, Rodríguez-López J, Rodríguez P.

Langmuir. 2017 Nov 21;33(46):13295-13302. doi: 10.1021/acs.langmuir.7b02465. Epub 2017 Nov 9.

PMID:
29088531
4.

InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.

Kosowski M, Kübler P, Kołodziej A, Krakowiak B, Kustrzycka-Kratochwil D, Sławin J, Sokolski M, Biegus J, Zymliński R, Banasiak W, Ponikowski P, Reczuch K.

Kardiol Pol. 2017;75(8):736-741. doi: 10.5603/KP.a2017.0096. Epub 2017 May 25.

5.

One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.

Kaye DM, Hasenfuß G, Neuzil P, Post MC, Doughty R, Trochu JN, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Walton A, Muller D, Walters D, Hausleiter J, Raake P, Petrie MC, Bergmann M, Jondeau G, Feldman T, Veldhuisen DJ, Ponikowski P, Silvestry FE, Burkhoff D, Hayward C.

Circ Heart Fail. 2016 Dec;9(12). pii: e003662.

6.

Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea: 12 months' experience with the remedē® System.

Jagielski D, Ponikowski P, Augostini R, Kolodziej A, Khayat R, Abraham WT.

Eur J Heart Fail. 2016 Nov;18(11):1386-1393. doi: 10.1002/ejhf.593. Epub 2016 Jul 4.

7.

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.

Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JG, Leon M, Kaye DM; REDUCE LAP-HF study investigators.

Lancet. 2016 Mar 26;387(10025):1298-304. doi: 10.1016/S0140-6736(16)00704-2.

PMID:
27025436
8.

Phrenic nerve stimulation for the treatment of central sleep apnea.

Abraham WT, Jagielski D, Oldenburg O, Augostini R, Krueger S, Kolodziej A, Gutleben KJ, Khayat R, Merliss A, Harsch MR, Holcomb RG, Javaheri S, Ponikowski P; remedē Pilot Study Investigators.

JACC Heart Fail. 2015 May;3(5):360-369. doi: 10.1016/j.jchf.2014.12.013. Epub 2015 Mar 11.

9.

Coronary collateral circulation is less developed when ischaemic heart disease coexists with diabetes.

Rzeczuch K, Jagielski D, Kołodziej A, Kaczmarek A, Mielnik M, Banasiak W, Ponikowski P.

Kardiol Pol. 2003 Feb;58(2):85-92.

PMID:
14504633

Supplemental Content

Loading ...
Support Center